Petti M C, Testa M G, Deb G, Amadori S
Biomedicine. 1980;33(6):188-90.
In vitro 3H-thymidine labeling index (LI) of the marrow leukemic cells was determined at diagnosis in 70 patients with chronic lymphocytic leukemia (CLL). Very little labeling of leukemic lymphocytes was observed, median LI resulting as low as 0.05%. The initial LI was unrelated to age, sex, absolute number of circulating lymphocytes, degree of marrow lymphocytosis, clinical staging or survival. We conclude that the initial LI% of the marrow leukemic cells is neither a valid nor practical prognostic factor in patients with CLL.
在70例慢性淋巴细胞白血病(CLL)患者诊断时测定了骨髓白血病细胞的体外3H-胸腺嘧啶核苷标记指数(LI)。观察到白血病淋巴细胞的标记极少,中位LI低至0.05%。初始LI与年龄、性别、循环淋巴细胞绝对数、骨髓淋巴细胞增多程度、临床分期或生存期无关。我们得出结论,骨髓白血病细胞的初始LI%在CLL患者中既不是一个有效的也不是实用的预后因素。